Sign in

CIK 0001178670

  • Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770602661
Phone
+1 617-551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-16 Greenstreet Yvonne Chief Executive Officer Sale −3,614 $148.24 $536K 45,979
2024-02-16 Greenstreet Yvonne Chief Executive Officer Sale −840 $149.03 $125K 45,139
2024-02-15 Garg Pushkal CMO & EVP Dev & Med Affairs Grant or award +4,295 8,640
2024-02-15 Poulton Jeffrey V. EVP, Chief Financial Officer Grant or award +3,278 19,151
2024-02-15 Tanguler Tolga EVP, Chief Commercial Officer Grant or award +3,278 5,079
2024-02-15 Greenstreet Yvonne Chief Executive Officer Grant or award +16,953 52,169
2024-02-02 Franchini Indrani Lall EVP, CLO & Secretary Sale −502 $170.01 $85K 4,673
2024-02-02 Franchini Indrani Lall EVP, CLO & Secretary Sale −820 $171.14 $140K 3,853
2024-02-02 Franchini Indrani Lall EVP, CLO & Secretary Sale −269 $172.38 $46K 3,584
2024-02-01 Franchini Indrani Lall EVP, CLO & Secretary Exercise or conversion +5,175 5,175
2024-02-01 Franchini Indrani Lall EVP, CLO & Secretary Exercise or conversion · Restricted Stock Units −5,175 5,175
2023-12-27 BONNEY MICHAEL W Director Exercise or conversion 10b5-1 +30,000 $96.45 $2.9M 46,029
2023-12-27 BONNEY MICHAEL W Director Sale 10b5-1 −30,000 $195.00 $5.8M 16,029
2023-12-27 BONNEY MICHAEL W Director Exercise or conversion · Stock Option (right to buy) 10b5-1 −30,000 0
2023-08-07 Garg Pushkal CMO & EVP Dev & Med Affairs Sale −3,112 $183.58 $571K 5,399
2023-08-07 Garg Pushkal CMO & EVP Dev & Med Affairs Sale −814 $184.65 $150K 4,585
2023-08-07 Garg Pushkal CMO & EVP Dev & Med Affairs Sale −240 $185.32 $44K 4,345
2023-08-04 Garg Pushkal CMO & EVP Dev & Med Affairs Sale −658 $184.70 $122K 11,314
2023-08-04 Garg Pushkal CMO & EVP Dev & Med Affairs Sale −1,593 $185.54 $296K 9,721
2023-08-04 Garg Pushkal CMO & EVP Dev & Med Affairs Sale −945 $186.39 $176K 8,776

Page 51 of 80 · 1,590 trades